About Lowcountry Lung and Critical Care
Clinical Trials at Lowcountry Lung and Critical Care
During the past decade, Lowcountry Lung and Critical Care conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 11 clinical trials were completed, i.e. on
average, 47.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 7 clinical trials were completed. i.e. 46.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Lowcountry Lung and Critical Care" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Jazz Pharmaceuticals" with 4 trials
sponsored, "FibroGen" with 2 trials sponsored, "Harmony Biosciences, LLC" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lowcountry Lung and Critical Care"
#1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Lowcountry Lung and Critical Care
According to Clinical.Site data, the most researched conditions in "Lowcountry Lung and Critical Care" are
"Idiopathic Pulmonary Fibrosis" (8 trials), "Chronic Obstructive Pulmonary Disease" (5 trials), "Narcolepsy" (5 trials), "Obstructive Sleep Apnea" (3 trials) and "Pulmonary Disease, Chronic Obstructive" (3 trials). Many other conditions were trialed in "Lowcountry Lung and Critical Care" in a lesser frequency.
Clinical Trials Intervention Types at Lowcountry Lung and Critical Care
Most popular intervention types in "Lowcountry Lung and Critical Care" are "Drug" (28 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "JZP-110" (3 trials), "Nintedanib" (3 trials), "BI 1015550" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Lowcountry Lung and Critical Care
The vast majority of trials in "Lowcountry Lung and Critical Care" are
30 trials for "All" genders.
Clinical Trials Status at Lowcountry Lung and Critical Care
Currently, there are NaN active trials in "Lowcountry Lung and Critical Care".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 20 completed trials in Lowcountry Lung and Critical Care,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Lowcountry Lung and Critical Care, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".